Assessing patient experience with a Telepharmacy model coordinated in the hospital and rural pharmacy setting: The TELEMACO project.
| Autor: | Morillo-Verdugo R; Pharmacy Department. Hospital de Valme. Sevilla. ralejandro.morillo.sspa@juntadeandalucia.es., Morillo-Lisa R; Pharmacy office Lda. Rosa Morillo Lisa, Alcalá de Ebro. rosamariamorillo@redfarma.org., Espolita-Suárez J; Pharmacy office Ldo. Jaime Espolita Suárez, Cabrillanes. dietoterap@gmail.com., Delgado-Sánchez O; Pharmacy Department. Hospital Son Spases. Palma de Mallorca. olga.delgado@ssib.es. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2022 Oct 30; Vol. 46 (7), pp. 128-133. Date of Electronic Publication: 2022 Oct 30. |
| Abstrakt: | Objective: To determine variation in patient experience with a model of Telepharmacy coordinated in the specialist hospital and rural pharmacy setting. Method: A pre-post experimental analytical study. A set of common essential pharmacy tasks based on the capacity-motivation-opportunity method will be performed in each participating site. A a Telepharmacy software will be designed to include the following functionalities: history of patient pharmaceutical profiling and prioritization; scheduled appointment book; unscheduled visit record; generic participant communication wall; patient- professional instantaneous messaging chat; video calls; monitoring of treatment adherence; and evaluation of patient-reported outcomes. Inclusion criteria: age older than 18 years; being on regular hospital pharmacy follow-up for the last 6 months; using a stable drug therapy (without treatment changes in the last 6 months); using a chronic hospital outpatient prescription (any prescription valid for at least 6 months); living in any of the municipalities served by the participating pharmacies or using the services of a participating pharmacy located near the usual place of residence; granting informed consent prior to inclusion in the study. A 48-week follow-up will be performed of each patient. The primary endpoint will be variation in patient experience, as assessed using the "Instrumento de Evaluación de la eXperiencia del PAciente Crónico" scale at baseline and at the end of the follow-up period. Conclusions: The incorporation, development and implementation of a coordinated Telepharmacy care model will help us determine whether this model is useful in improving patient follow-up and communication with pharmacy professionals at different levels of healthcare. (Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|